AzTrials
AzTrials

Osteochondritis DissecansNCT02771496

Osteochondritis Dissecans of Knee Prospective Cohort

An observational study of Osteochondritis Dissecans, run by University of Pennsylvania at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Cohort is a multi-site prospective data collection study that will enroll any patient with diagnosis of knee OCD (confirmed by a standard of care x-ray or MRI). Patients will be followed for up to the next 50 years of their lives to study courses of care, disease progression, treatment/surgical options/results… Read more about this study

Who is it for?
Any age
Conditions the study is for
Osteochondritis Dissecans
How many people
3,000 participants
Where
1 siteUnited States
Study dates
1 May 2014to 1 Dec 2074
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients of all ages with osteochondritis dissecans (OCD) or focal articular cartilage defects confirmed via MRI or x-ray.

Who may be able to join

  • Diagnosis of osteochondritis dissecans or focal articular cartilage defects as confirmed by x-ray or MRI

Who cannot join

  • Non-confirmed diagnosis (i.e. patient does not yet have imaging confirmation)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

    Mounika Ponakala, BS, Mounika.Ponakala@Pennmedicine.upenn.edu

    James L Carey, MD

    Recruiting

Other trials in United States

About this study

Official title: ROCK Comprehensive Prospective Cohort for Osteochondritis Dissecans of the Knee

The Cohort is a multi-site prospective data collection study that will enroll any patient with diagnosis of knee OCD (confirmed by a standard of care x-ray or MRI). Patients will be followed for up to the next 50 years of their lives to study courses of care, disease progression, treatment/surgical options/results, and specific sports-related outcomes in athletic patients. Subjects will complete quality of life surveys as part of the Cohort. Course of care will not be affected.

Read the detailed description

Patients will be recruited and consented at the visit in which their eligibility is determined. Once a patient is eligible and provides informed consent, he or she will be in the study for up to 50 years, or until his or her OCD lesion is healed successfully.

At the initial visit, a subject will complete a basic medical history form, and three questionnaires: the IKDC Subjective questionnaire (ages over 18) or the PEDI-IKDC Subjective questionnaire (ages under 18); the KOOS questionnaire; and the Marx Activity Scale (adult) or Pedi-FABS Scale (pediatric). Patients will then continue with their normal course of care as determined by their surgeon and care team.

Mandatory surveys (same as above) will be collected from patients at 2 years, 5 years, 10 years, and 25 years. Patients who cannot return to clinic will have the option to complete the assessments and return in pre-stamped and addressed return envelopes provided by the clinical site the subject is a patient at. Any other follow-up visits between these time intervals will also be options for patients to complete these assessments, however patients will not complete them any closer than intervals 12 weeks apart in order to prevent redundancy.

Additionally, at the initial visit, the surgeon will complete a routine patient history and physical exam, which will be collected. Any surgical procedures or physical therapy a patient undergoes for treatment of his or her OCD lesion will also be documented and collected. At follow-up visits, surgeons will complete their own physical exam follow-up assessment forms, which will be collected.

Being tested
Other: observational only- no intervention
Medical subject headings
Osteochondritis Dissecans

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Other: observational only- no interventionOther

    Other: observational only- no intervention

Study groups in NCT02771496
Study groupRoleWhat they receive
Patients with OCDPatients with diagnosis of OCD as confirmed by x-ray or MRI. Surveys collected from patients at 2 years, 5 years, 10 years, and 25 years.
Receives: Other: Other: observational only- no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. IKDC questionnaire

    The primary outcome endpoint for this study is the patient's score on the IKDC Subjective questionnaire, or PEDI-IKDC Subjective questionnaire for patients under 18 years of age.

    Measured: baseline up to 50 years

  2. PEDI-IKDC questionnaire

    The primary outcome endpoint for this study is the patient's score on the IKDC Subjective questionnaire, or PEDI-IKDC Subjective questionnaire for patients under 18 years of age.

    Measured: baseline up to 50 years

Secondary outcomes (4)
  1. KOOS Knee score

    The Knee injury and Osteoarthritis Outcome Score (KOOS) evaluates short-term and long-term symptoms and function in subjects with knee injury and osteoarthritis.

    Measured: baseline up to 50 years

  2. Marx Activity Score questionnaire

    Measure of physical activity at healthiest and most active state from time of taking to year prior.

    Measured: baseline up to 50 years

  3. Pedi-FABS Score

    An eight-item scale that measures level of physical activity and fitness.

    Measured: baseline up to 50 years

  4. Radiographic Healing

    Visualization of bone healing through x-ray images.

    Measured: baseline up to 50 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2016 (estimated)
  2. Study start1 May 2014
  3. Primary completion1 May 2074 (estimated)
  4. Study completion1 Dec 2074 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
3,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02771496
Sponsor's protocol ID
820147
Status last verified
May 2026
First submitted
10 May 2016
Last updated
27 May 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • ROCK Group; Nissen CW, Albright JC, Anderson CN, Busch MT, Carey JL, Carlson C, Carsen S, Chambers HG, Crepeau A, Edmonds EW, Ellermann JM, Ellis HB Jr, Erickson JB, Fabricant PD, Godin J, Ganley TJ, Green DW, Grimm NL, Heyworth BE, Hui Hoi Po J, Kocher MS, Koehler R, Krych AJ, Latz KH, Loveland DM, Lyon RM, Meenen NM, Milewski MD, Myer GD, Nelson BJ, Nepple JJ, Nguyen JC, Pace JL, Paterno MV, Pennock AT, Perkins CA, Polousky JD, Riley P, Saluan P, Shea KG, Tompkins MA, Wall EJ, Weiss JM, Willimon SC, Wilson PL, Wright RW, Kostyun RO. The Efficacy of Bracing in Nonoperative Care of Medial Femoral Condyle Osteochondritis Dissecans: A Study From the Research in Osteochondritis Dissecans of the Knee (ROCK) Study Group. Am J Sports Med. 2026 May;54(6):1415-1422. doi: 10.1177/03635465261429407. Epub 2026 Apr 14.

    PubMed 41981903

Questions about this trial

What is this clinical trial studying?

An observational study of Osteochondritis Dissecans, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mounika Ponakala, MS (6093343767, mounika.ponakala@pennmedicine.upenn.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

IKDC questionnaire (time frame: baseline up to 50 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02771496, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in